85 results
Page 3 of 5
424B3
6u1enjusm3tlqn6qdeqs
4 Feb 19
Prospectus supplement
5:52pm
S-4/A
3kdvygjv
14 Jan 19
Registration of securities issued in business combination transactions (amended)
12:00am
S-4
nlo d642fmv
4 Jan 19
Registration of securities issued in business combination transactions
5:05pm
8-K
EX-99.1
wcilnvf
4 Dec 18
Completion of Acquisition or Disposition of Assets
10:47am
425
ukxbs8phkrh7 25xy
8 Nov 18
Business combination disclosure
9:54pm
425
EX-2.1
1mw7r985
8 Nov 18
Business combination disclosure
6:41am
8-K
EX-2.1
7xypcmnq eb9
8 Nov 18
BioTime and ASTERIAS BIOTHERAPEUTICS enter into definitive merger agreement TO CREATE leading cell therapy company
6:41am
8-K
EX-99.1
0jdrw5o5dwzu9xfgn
8 Nov 18
BioTime ReportS Third Quarter 2018 Financial Results AND PROVIDES BUSINESS UPDATE
6:40am
425
EX-99.1
igg970lop5npq0t
8 Nov 18
Business combination disclosure
6:40am
8-K
EX-99.1
icgoe5o 535l0m1y6
2 Aug 18
BioTime Reports Second Quarter Results and Recent Corporate Accomplishments
4:13pm
8-K
EX-99.1
44bu ov0sk08jvcjced
10 May 18
BioTime Reports First Quarter Results and Recent Corporate Accomplishments
4:24pm